Our team will grow…..

A/Prof Erin McMeniman, Specialist Dermatologist

BSc, MBBS, FRACGP, MPH, PhD, FACD.

  • Visiting Medical Officer, Department of Dermatology, Princess Alexandra Hospital and Inala Indigenous Health Centre of Excellence, Queensland Health.

  • Past Chair, The Queensland Faculty of Dermatology.

  • Co-Chair, The Australasian College of Dermatology Aboriginal and Torres Strait Islander Affairs Committee.

  • Member, The Curriculum Committee of Australasian College of Dermatology and Selection Committee.

  • Nominee UQ Athena Swan Women in STEM award.

  • Australian Society Dermatology Research ‘Women in Skin Research’ Award 2025 recipient.

Having obtained her undergraduate medical degree in 2003 from The University of Queensland Assoc. Prof. McMeniman subsequently completed a Master of Public Health at The University of Queensland with a dissertation project in skin diseases in indigenous children. She completed her advanced training in dermatology in Queensland and was awarded a fellowship of the Australasian College of Dermatology. Post fellowship she completed her PhD on genetic mutations associated with multiple primary melanoma.

Assoc. Prof. McMeniman conducts a medical dermatology clinic 2 sessions per week at The Princess Alexandra Hospital, treating a broad range of complex auto-immune, auto-inflammatory and reactive dermatoses. She has developed hospital based multi-disciplinary clinics treating Hidradenitis Suppurativa and Cutaneous Lymphoma.

Assoc. Prof. McMeniman’s published works include:

  • Danesh, M., Pomeranz, M. K., McMeniman, E., & Murase, J. E. (2016). Dermatoses of pregnancy: Nomenclature, misnomers, and myths. Clinics in Dermatology, 34(3), 314–319. https://doi.org/10.1016/j.clindermatol.2016.02.002

  • Kunde, L., McMeniman, E., & Parker, M. (2013). Clinical photography in dermatology: ethical and medico-legal considerations in the age of digital and smartphone technology: Clinical photography in dermatology. The Australasian Journal of Dermatology, 54(3), 192–197. https://doi.org/10.1111/ajd.12063

  • McMeniman, E. K., Duffy, D. L., Jagirdar, K., Lee, K. J., Peach, E., McInerney-Leo, A. M., De’Ambrosis, B., Rayner, J. E., Smithers, B. M., Soyer, H. P., & Sturm, R. A. (2020). The interplay of sun damage and genetic risk in Australian multiple and single primary melanoma cases and controls. The British Journal of Dermatology, 183(2), 357–366. https://doi.org/10.1111/bjd.18777

  • McMeniman, E., Moore, R., Yelland, M., & McClure, R. (2011). Childhood obesity: how do Australian general practitioners feel about managing this growing health problem? Australian Journal of Primary Health, 17(1), 60–65. https://doi.org/10.1071/PY10041

  • Ngoo, A., Finnane, A., McMeniman, E., Tan, J.-M., Janda, M., & Soyer, H. P. (2018). Efficacy of smartphone applications in high-risk pigmented lesions. The Australasian Journal of Dermatology, 59(3), e175–e182. https://doi.org/10.1111/ajd.12599

  • Ong, N., McMeniman, E., Pillans, P., & Soyer, H. P. (2017). A clinical audit of high-cost and off-label drug use in dermatology: Use of high-cost drugs in dermatology. The Australasian Journal of Dermatology, 58(1), 30–34. https://doi.org/10.1111/ajd.12392

  • Rayner, J. E., McMeniman, E. K., Duffy, D. L., De’Ambrosis, B., Smithers, B. M., Jagirdar, K., Lee, K. J., Soyer, H. P., & Sturm, R. A. (2019). Phenotypic and genotypic analysis of amelanotic and hypomelanotic melanoma patients. Journal of the European Academy of Dermatology and Venereology: JEADV, 33(6), 1076–1083. https://doi.org/10.1111/jdv.15446

  • Rayner, Jenna E., Jagirdar, K., Soyer, P. H., & McMeniman, E. K. (2017). Patients’ and doctors’ preferences for disclosing dermatology results. The Australasian Journal of Dermatology, 58(4), e282–e283. https://doi.org/10.1111/ajd.12707

  • Rayner, Jenna E., McMeniman, E. K., Duffy, D. L., De’Ambrosis, B., Smithers, B. M., Jagirdar, K., Lee, K. J., Soyer, H. P., & Sturm, R. A. (2019). IRF4 rs12203592*T/T genotype is associated with nodular melanoma. Melanoma Research, 29(4), 445–446. https://doi.org/10.1097/CMR.0000000000000596

  • Saunte, D. M., Boer, J., Stratigos, A., Szepietowski, J. C., Hamzavi, I., Kim, K. H., Zarchi, K., Antoniou, C., Matusiak, L., Lim, H. W., Williams, M., Kwon, H. H., Gürer, M. A., Mammadova, F., Kaminsky, A., Prens, E., van der Zee, H. H., Bettoli, V., Zauli, S., … Jemec, G. B. E. (2015). Diagnostic delay in hidradenitis suppurativa is a global problem. The British Journal of Dermatology, 173(6), 1546–1549. https://doi.org/10.1111/bjd.14038

  • Sinnya, S., Jagirdar, K., De’Ambrosis, B., McMeniman, E., Sturm, R. A., & Soyer, H. P. (2015). High incidence of primary melanomas in an MC1R RHC homozygote/CDKN2A mutant genotype patient. Archives of Dermatological Research, 307(8), 741–745. https://doi.org/10.1007/s00403-015-1582-y

  • Susanto, A., Nathan, V., Janda, M., Khosrotehrani, K., McMeniman, E., Soyer, H. P., & Betz-Stablein, B. (2024). Diversifying dermatology: Improving skin of colour representation. The Australasian Journal of Dermatology, 65(7), e208–e210. https://doi.org/10.1111/ajd.14356